{
    "code": "01038138",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01038138",
    "time": "2022-04-29 03:30:52",
    "許可證字號": "衛署藥製字第038138號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/09\/27",
    "發證\/登錄日期": "83\/09\/27",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00103813801",
    "中文品名": "&quot;人人&quot; 溴敏達酏劑",
    "英文品名": "EXTAMINE-P ELIXIR &quot;GCPC&quot;",
    "適應症": "緩解過敏性鼻炎、枯草熱所引起之相關症狀（鼻塞、流鼻水、打噴嚏、眼部及喉部搔癢。",
    "劑型": "175酏劑",
    "包裝": "4000ml以下塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "17醫師藥師藥劑生指示藥品",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "BROMPHENIRAMINE MALEATE, PHENYLEPHRINE HCL",
    "限制項目": "01國　產",
    "申請商名稱": "0201504200  人人化學製藥股份有限公司",
    "申請商地址": "桃園市中壢區南園二路３號",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099101 抗過敏抗組織胺用藥Drugs for antihypersensitivity and antihistamine",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400000510",
            "成分名稱": "BROMPHENIRAMINE MALEATE",
            "含量描述": "",
            "含量": "0.8000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1212002310",
            "成分名稱": "PHENYLEPHRINE HCL",
            "含量描述": "",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單-108-12-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01038138&Seq=002&Type=9"
        },
        {
            "title": "標籤-108-12-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01038138&Seq=002&Type=8"
        },
        {
            "title": "支盒-108-12-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01038138&Seq=001&Type=8"
        }
    ]
}